Veterinary Medicines

GALASTOP

Authorised
  • Cabergoline
Download as PDF

Product identification

Medicine name:
GALASTOP
Active substance:
  • Cabergoline
Target species:
  • Dog (bitch)
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Cabergoline
    0.05
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral drops, solution
Withdrawal period by route of administration:
  • Oral use
    • Dog (bitch)
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QG02CB03
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Ceva Sante Animale
Marketing authorisation date:
Manufacturing sites for batch release:
  • Ceva Sante Animale
  • Vetem SPA
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/6609046 1/1992
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 8/07/2024
Download

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 2/09/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."